Domenico De Grandis

Summary

Country: Italy

Publications

  1. ncbi Acetyl-L-carnitine (levacecarnine) in the treatment of diabetic neuropathy. A long-term, randomised, double-blind, placebo-controlled study
    Domenico De Grandis
    Department of Neuroscience, Ospedale Civile, Rovigo, Italy
    Drugs R D 3:223-31. 2002
  2. ncbi Clinical features and neurophysiological follow-up in a case of Brown-Vialetto-Van Laere syndrome
    D De Grandis
    Department of Neurology, Rovigo Hospital, Ospedale Civile Rovigo, Viale Tre Martiri, 45100 Rovigo, Italy
    Neuromuscul Disord 15:565-8. 2005
  3. ncbi Acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy: a short review
    Domenico De Grandis
    Divisione di Neurologia, Ospedale Civile di Rovigo, Rovigo, Italy
    CNS Drugs 21:39-43; discussion 45-6. 2007

Detail Information

Publications3

  1. ncbi Acetyl-L-carnitine (levacecarnine) in the treatment of diabetic neuropathy. A long-term, randomised, double-blind, placebo-controlled study
    Domenico De Grandis
    Department of Neuroscience, Ospedale Civile, Rovigo, Italy
    Drugs R D 3:223-31. 2002
    ..To assess the efficacy and tolerability of acetyl-L-carnitine (levacecarnine; LAC) versus placebo in the treatment of diabetic neuropathy, mainly by evaluating the effects of treatment on electrophysiological parameters and pain symptoms...
  2. ncbi Clinical features and neurophysiological follow-up in a case of Brown-Vialetto-Van Laere syndrome
    D De Grandis
    Department of Neurology, Rovigo Hospital, Ospedale Civile Rovigo, Viale Tre Martiri, 45100 Rovigo, Italy
    Neuromuscul Disord 15:565-8. 2005
    ....
  3. ncbi Acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy: a short review
    Domenico De Grandis
    Divisione di Neurologia, Ospedale Civile di Rovigo, Rovigo, Italy
    CNS Drugs 21:39-43; discussion 45-6. 2007
    ..The present studies support the use of ALC in cancer patients with persisting neurotoxicity induced by paclitaxel or cisplatin treatment...